Cargando…

Efficacy of the Combination of Voriconazole and Caspofungin in Experimental Pulmonary Aspergillosis by Different Aspergillus Species

OBJECTIVES: Invasive pulmonary aspergillosis (IPA) caused by Aspergillus fumigatus, Aspergillus flavus, or Aspergillus niger is associated with high mortality. We evaluated the efficacy and compared the therapeutic effect differences of voriconazole (VRC) in combination with caspofungin (CAS) in tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ming, Su, Xin, Sun, Wen-Kui, Chen, Fei, Xu, Xiao-Yong, Shi, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915080/ https://www.ncbi.nlm.nih.gov/pubmed/24306184 http://dx.doi.org/10.1007/s11046-013-9719-z

Ejemplares similares

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011)

Are Systemic Voriconazole and Caspofungin Ototoxic? An Experimental Study with Rats
por: Aydın, Emine, et al.
Publicado: (2012)

Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis
por: Ullmann, Irina, et al.
Publicado: (2022)

Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole
por: López-Ciudad, Víctor, et al.
Publicado: (2006)

Dexamethasone/voriconazole: Invasive pulmonary aspergillosis secondary to Aspergillus terreus and treatment failure: case report
Publicado: (2021)

Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofungin
por: Chok, Lionel, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Evidence Supporting a Role for Mammalian Chitinases in Efficacy of Caspofungin against Experimental Aspergillosis in Immunocompromised Rats
por: Verwer, Patricia E. B., et al.
Publicado: (2013)

In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
por: Gheith, Soukeina, et al.
Publicado: (2014)

Voriconazole: Lack of efficacy during treatment of invasive pulmonary aspergillosis: 2 case reports
Publicado: (2021)

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
por: Cadranel, J., et al.
Publicado: (2012)

Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the U.S
por: Ascioglu, Sibel, et al.
Publicado: (2014)

Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia
por: Lee, Kyu Ho, et al.
Publicado: (2017)

1639. Efficacy of Voriconazole Prophylaxis Followed by Therapeutic Liposomal Amphotericin B for the Treatment of Murine Pulmonary Aspergillosis Caused by Azole-Resistant Aspergillus fumigatus Strains
por: Olson, Jon, et al.
Publicado: (2018)

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
por: Cesaro, Simone, et al.
Publicado: (2007)

Virulence capacity of different Aspergillus species from invasive pulmonary aspergillosis
por: Chen, Biao, et al.
Publicado: (2023)

Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between Sensititre(TM) YeastOne(TM) and MIC Test Strip
por: Lo Cascio, Giuliana, et al.
Publicado: (2022)

Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment?
por: Ohlstein, Derek H., et al.
Publicado: (2012)

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
por: Gu, Li, et al.
Publicado: (2023)

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole
por: Jacobs, F., et al.
Publicado: (2011)

Phosphoproteomics of Aspergillus fumigatus Exposed to the Antifungal Drug Caspofungin
por: Mattos, Eliciane Cevolani, et al.
Publicado: (2020)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
por: Grau, Santiago, et al.
Publicado: (2016)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole
por: Teng, Guo-Jie, et al.
Publicado: (2020)

Aspergillus Niger-pulmonary Aspergillosis in an Immunocompetent Woman
por: Otsuka, Rikako, et al.
Publicado: (2021)

Aspergillus fumigatus Transcription Factors Involved in the Caspofungin Paradoxical Effect
por: Valero, Clara, et al.
Publicado: (2020)

Signaling Pathways Governing the Caspofungin Paradoxical Effect in Aspergillus fumigatus
por: Papon, Nicolas, et al.
Publicado: (2020)

The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis
por: Kosmidis, Chris, et al.
Publicado: (2020)

1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
por: Le Daré, Brendan, et al.
Publicado: (2021)

Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole
por: Ader, Florence, et al.
Publicado: (2009)

Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022)

Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis
por: Hamada, Noboru, et al.
Publicado: (2021)

Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins
por: Biswal, Sasmita
Publicado: (2012)

Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis
por: Mehta, Hijab, et al.
Publicado: (2008)

Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole
por: Nazik, Hasan, et al.
Publicado: (2017)

Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis
por: Person, A. K., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_910m3alkb5kqlmr8u45pikf5jv